Several drugs now used to treat cancer and autoimmune diseases are actually repurposed tools derived from the immune system. One of the ways these "therapeutic antibodies" work is to grab onto malignant or inflammatory cells ...
Feb 12, 2015
0
14
Scientists at the University of York have discovered that a drug used widely to combat epilepsy has the potential to reduce the growth and spread of breast cancer.
Jan 27, 2015
0
4
A genetic misfire called the 3q26.2 amplicon can cause real havoc. In fact, it is among the most frequent chromosomal aberrations seen in many cancers, including ovarian and breast cancers.
Dec 8, 2014
0
0
The University of Chicago is collaborating with the National Cancer Institute to establish the nation's most comprehensive computational facility that stores and harmonizes cancer genomic data generated through NCI-funded ...
Dec 2, 2014
0
0
In a second presentation looking at new ways of treating non-small cell lung cancer (NSCLC) that has both the EGFR and T790M mutations, researchers will tell the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer ...
Nov 20, 2014
0
1
Patients with a form of advanced colorectal cancer that is driven by a mutated version of the BRAF gene have limited treatment options available. However, results from a multi-centre clinical trial suggest that the cancer ...
Nov 20, 2014
0
0
A new drug that targets not only common cancer-causing genetic mutations in patients with non-small cell lung cancer (NSCLC), but also a form of the mutation that causes resistance to treatment, has shown promising results ...
Nov 19, 2014
0
1
Scientists have discovered mechanisms that control a new form of premature cell death in living tissue - called ferroptosis - and a mechanism to reverse it.
Nov 18, 2014
0
0
Scientists at the University of York have identified a therapeutic target which could lead to the development of new treatments for specific blood cancers.
Nov 10, 2014
0
0
In a new study published in the scientific journal Oncotarget researchers from Uppsala University show that a therapeutic vaccine directed against tumor vessels can reduce tumor burden and suppress formation of spontaneous ...
Nov 7, 2014
0
0
